
Call for Abstract
1. Oral Presentation
2. Poster Presentation
Deadline
Abstract Submission Deadline: March 25th, 2025
Acceptance Notification : March 28th, 2025
Full Paper Submission: April 10th, 2025
Topic For Abstract
Abstract will be categorized into following fields:
- Human, Animal, and Environmental Health Interconnections: Exploring the dynamics between human health, animal health, and ecosystems, focusing on integrated solutions.
- Infectious and Zoonotic Diseases: Research on prevention, control, and management of diseases transmitted between animals and humans.
- Sustainable Public Health Practices: Developing strategies for sustainable healthcare systems and equitable access to health resources.
- Environmental and Ecosystem Preservation: Examining the impact of environmental changes and promoting initiatives to sustain biodiversity and ecological balance.
- Pharmacological Innovations: Advancing drug discovery, pharmacogenomics, and biotechnology to address current and emerging health challenges.
General Information:
- Author (presenter) must register as participant to submit their research.
- One participant can submit/present multiple abstract
- Abstracts should be submitted through the link provided in the registration form.
- All abstracts must be submitted and presented in English.
- The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
- All abstracts will be reviewed by the Scientific Committee.
- Author can choose poster or oral during the registration. However, the scientific committee will give a confirmation whether it can be presented as oral or poster
- Presenting author will be notified via e-mail by March 28th of their notification acceptance.
- The abstract will be published in an abstract book.
- Selected abstracts may proceed to international publication indexed in Scopus (upon agreement and additional fee)
Abstract Preparation Guideline:
- All abstracts must be original work.
- All abstracts must be submitted online with Microsoft Word file attachment.
- Abstract must be typed in English: font type-Arial, font size-11pt, spacing 1.5, paper size A4 (21 cm x 29.7 cm).
- The abstract must not exceed the 350 word limit, excluding the tittle and authors.
- Abstract tittle is written in CAPITAL LETTERS.
- Authors’ full name shall be written by first name and followed by family name in upper and lower case.
- Primary author(s) is the first mentioned. The presenter is underlined.
- Affiliation details should include the department, institution/hospital, city/state, country in sequences.
- Use generic name of drugs. Express numbers as numerals.
- Abstract contains only Text. Any table/graphs/diagrams should not be included in the abstract.
- The abstract consist of four parts: Background/Objective, Methods, Results, and Conclusion.
- Download the abstract template from the following link: Abstract template
Full Paper Submission
- The Paper Should be written in English.
- View the theme and scope topics.
- It should be a full article. There is no limit as regards the maximum number of pages. However, ensure your content is relevant, useful to the community, and with no redundant information.
- The paper format is as follows:
1) Some tips on how to write a TITLE and an ABSTRACT properly are given in this document
2) Word Format A4 (210 x 297 mm), one column: DOWNLOAD HERE
3) References: Any styles are allowed but must be formatted using any reference management tool, e.g., Mendeley, Endnote, Zotero - All review processes are double-blind peer reviews by at least two reviewers.
- The full paper must be submitted through https://seminar.uad.ac.id/index.php/adicohs/index
- Please get in touch with adicohs@uad.ac.id with the inquiry.
Full paper submission will be submitted through OJS system in this link: Website for submission